Bayer’s in silico ADMET platform: a journey of machine learning over the past two decades

This paper was originally published by Andreas H. Göller, Lara Kuhnke, Floriane Montanari, Anne Bonin, Sebastian Schneckener, Antoniuster Laak, Jörg Wichard, Mario Lobell, and Alexander Hillisch in Drug Discovery Today (Vol 25, Iss 9) under a Creative Commons license. Abstract Over the past two decades, an in silico absorption, distribution, metabolism, and excretion (ADMET) platform has been […] Source